Breaking News, Collaborations & Alliances

Tetra Pharm Technologies, Kvantify Partner to Accelerate Discovery of Novel Drug Candidates

Aim to transform the landscape of endocannabinoid system-targeted drug discovery.

Author Image

By: Charlie Sternberg

Associate Editor

Tetra Pharm Technologies and Kvantify have partnered to accelerate the identification and development of novel drug candidates targeting the endocannabinoid system (ECS).   “This partnership will expedite our drug development process and significantly expand our pipeline of promising drug candidates in 2024,” says Martin Rose, CEO of Tetra Pharm Technologies.   The partnership’s aim is to transform the landscape of ECS-targeted drug discovery, potentially leading to significant a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters